Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lleo

Showing results (21-30 of 202) with videos related to

Pageof 21
Sort By:
Seminars in Liver Disease|May 24, 2007
Interpreting serological tests in diagnosing autoimmune liver diseasesPietro Invernizzi, Ana Lleo, Mauro Podda
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2019
Hepatotoxicity of immune check point inhibitors: Approach and managementAna Lleo, Lorenza Rimassa, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2017
Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?Massimo Colombo, Savino Bruno, Ana Lleo
Clinics in Liver Disease|November 24, 2015
Making Sense of Autoantibodies in Cholestatic Liver DiseasesSimona Marzorati, Pietro Invernizzi, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2022
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?Benedetta Terziroli Beretta-Piccoli, Ana Lleo
Clinical Reviews in Allergy & Immunology|September 29, 2021
Antimitochondrial Antibodies: from Bench to BedsideFrancesca Colapietro, Ana Lleo, Elena Generali
Journal of Hepatology|May 1, 2026
From science to public health impact: enacting the recommendations of the EASL-Lancet Commission on liver health in EuropeShira Zelber-Sagi, Ana Lleo, Debbie Shawcross
Journal of Translational Autoimmunity|January 23, 2023
PPAR agonists for the treatment of primary biliary cholangitis: Old and new talesFrancesca Colapietro, M Eric Gershwin, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2018
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antiviralsVincenzo Craviotto, Laura Lamonaca, Alessio Aghemo, et al.
Journal of Autoimmunity|March 14, 2019
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicineLorenza Rimassa, Nicola Personeni, Alessio Aghemo, et al.
Pageof 21

Showing results (21-30 of 202) with videos related to

Sort By:
Pageof 21
Seminars in Liver Disease|May 24, 2007
Interpreting serological tests in diagnosing autoimmune liver diseasesPietro Invernizzi, Ana Lleo, Mauro Podda
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2019
Hepatotoxicity of immune check point inhibitors: Approach and managementAna Lleo, Lorenza Rimassa, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2017
Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?Massimo Colombo, Savino Bruno, Ana Lleo
Clinics in Liver Disease|November 24, 2015
Making Sense of Autoantibodies in Cholestatic Liver DiseasesSimona Marzorati, Pietro Invernizzi, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2022
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?Benedetta Terziroli Beretta-Piccoli, Ana Lleo
Clinical Reviews in Allergy & Immunology|September 29, 2021
Antimitochondrial Antibodies: from Bench to BedsideFrancesca Colapietro, Ana Lleo, Elena Generali
Journal of Hepatology|May 1, 2026
From science to public health impact: enacting the recommendations of the EASL-Lancet Commission on liver health in EuropeShira Zelber-Sagi, Ana Lleo, Debbie Shawcross
Journal of Translational Autoimmunity|January 23, 2023
PPAR agonists for the treatment of primary biliary cholangitis: Old and new talesFrancesca Colapietro, M Eric Gershwin, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2018
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antiviralsVincenzo Craviotto, Laura Lamonaca, Alessio Aghemo, et al.
Journal of Autoimmunity|March 14, 2019
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicineLorenza Rimassa, Nicola Personeni, Alessio Aghemo, et al.
Pageof 21